HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes

Bohlius, Julia; Schmidlin, Kurt; Boué, François; Fätkenheuer, Gerd; May, Margaret; Caro-Murillo, Ana Maria; Mocroft, Amanda; Bonnet, Fabrice; Clifford, Gary; Paparizos, Vassilios; Miro, Jose M; Obel, Niels; Prins, Maria; Chêne, Geneviève; Egger, Matthias (2011). HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes. Blood, 117(23), pp. 6100-6108. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-08-301531

[img] Text
Bohlius Blood 2011.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (289kB) | Request a copy

The risk of Hodgkin lymphoma (HL) is increased in patients infected with HIV-1. We studied the incidence and outcomes of HL, and compared CD4⁺ T-cell trajectories in HL patients and controls matched for duration of combination antiretroviral therapy (cART). A total of 40 168 adult HIV-1-infected patients (median age, 36 years; 70% male; median CD4 cell count, 234 cells/μL) from 16 European cohorts were observed during 159 133 person-years; 78 patients developed HL. The incidence was 49.0 (95% confidence interval [CI], 39.3-61.2) per 100,000 person-years, and similar on cART and not on cART (P = .96). The risk of HL declined as the most recent (time-updated) CD4 count increased: the adjusted hazard ratio comparing more than 350 with less than 50 cells/μL was 0.27 (95% CI, 0.08-0.86). Sixty-one HL cases diagnosed on cART were matched to 1652 controls: during the year before diagnosis, cases lost 98 CD4 cells (95% CI, -159 to -36 cells), whereas controls gained 35 cells (95% CI, 24-46 cells; P < .0001). The incidence of HL is not reduced by cART, and patients whose CD4 cell counts decline despite suppression of HIV-1 replication on cART may harbor HL.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Bohlius, Julia; Schmidlin, Kurt and Egger, Matthias




American Society of Hematology




Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

09 Sep 2017 00:00

Publisher DOI:


PubMed ID:


Web of Science ID:




URI: (FactScience: 212461)

Actions (login required)

Edit item Edit item
Provide Feedback